Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The Future of the Oocyte
Since the first successful transfer of an in vitro fertilised human egg in 1976, modern endocrinology, genetics, and assisted reproductive technologies have opened new frontiers of research with the aim to treat infertile women. In this workshop we set out to promote an interdisciplinary discussion between experts from various fields of basic, company-based and clinical research related to folliculogenesis and oocyte development. The aim of this workshop was to present, discuss and assess novel approaches in mammalian folliculogenesis and oocyte development that may have an impact on fertility/ infertility in the near or distant future. Key issues were the understanding of new modulators of folliculogenesis and regulators of cytoplasmic as well as meiotic oocyte maturation, modern technologies, the aging oocyte and pathogenetic mechanisms of infertility.
New Molecular Mechanisms of Estrogen Action and Their Impact on Future Perspectives in Estrogen Therapy
From our current knowledge, it is obvious that estrogen action in volves more than reproduction and fertility. Rather, estrogens affect and influence a number of other organ systems such as the immune, cardiovascular and central nervous system as well as the gastrointes tinal tract, urinary tract and skeleton. The importance of estrogens and estrogen receptor activity is appreciated from the spectrum of significant physiological dysfunctions that occur when there is a loss The participants of the workshop VI Preface of the hormone or the receptor activity. Loss of estrogen, however (for instance during menopause), occurs with time and results in a variety of clinical conditions. We know that...
Tissue-Specific Estrogen Action
Current molecular understanding of estrogen action has greatly profited from advances in molecular cell biology. These advances, and their implications for clinical use, were discussed by leading researchers from industry and academia during an international symposium held in Berlin, 1-3 March 2006 and are featured in this volume.
Directory of Members
None
The Uteroglobin/Clara Cell Protein Family
The discovery of this family of proteins three decades ago launched a broad range of research effort that now reaches across many potential applications in human reproductive biology, inflammatory diseases, endocrinology, and in oncology. These proceedings papers extend the new function research possibilities inherent in the structure of this steroid-inducible, multifunctional secreted protein, and in the UG-bioactive-derived peptides. An opening overview of the UG family focuses on mammaglobin and its implications with human breast cancer; the sequence/structure sections review applications of antiflammin responses from its peptide. Other sections present new research on regulation of uteroglobin genes by cytokines and hormones; and clinical applications for renal diseases, in targeting gene therapy in pulmonary disease. Together, these developments raise the possibility of cytokine/chemokine-like functions that play important roles in major public health problems. A consensus of nomenclature for Uteroglobin/Clara Cell 10kDa family of proteins is also advanced as a step to coordinating new areas of research for these promising proteins and receptors.
